It seems to make a whole lot of sense to me. When I was working on Alzheimer's disease, we did an intensive study on the costs to caregivers and collected national data on that. We were able to model it.
One of the advantages of the study that Dr. Bray described is that not only does it collect facts and figures about how many cases, but it also feeds those into the simulation modelling that allows us to model the impact of varying policy approaches to things such as caregiver support on an economic basis. That is an additional connection between the more basic science and clinical research and policy formation.